128 filings
Page 3 of 7
424B3
n3uzsmx113b
22 Sep 23
Prospectus supplement
4:08pm
425
9j2qcm7
22 Sep 23
Business combination disclosure
12:55pm
8-K
ifbase 8ntvmglt
22 Sep 23
Entry into a Material Definitive Agreement
12:55pm
425
62l 2i6fjirpqvkn
22 Sep 23
Business combination disclosure
9:27am
8-K
zyh 1gvw46
22 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
9:26am
424B3
43vxewtt1s4zo
21 Sep 23
Prospectus supplement
7:31pm
425
dyhy85i
19 Sep 23
Business combination disclosure
3:52pm
8-K
s8tvrq423i bm1
19 Sep 23
Entry into a Material Definitive Agreement
3:51pm
425
x3ej0
18 Sep 23
Business combination disclosure
9:26am
8-K
zyg14ralhb432kch
18 Sep 23
Entry into a Material Definitive Agreement
9:25am
425
u0nlu
14 Sep 23
Business combination disclosure
9:31am
8-K
tvdzo svl
14 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
9:30am
425
22nrpjqpt n0iaqw9dz
11 Sep 23
Business combination disclosure
11:30am
8-K
2kyjy0jau4s a4j8
11 Sep 23
Graf Acquisition Corp. IV Announces Adjournment of Special Meeting
11:30am
425
dubrgf wbq
30 Aug 23
Business combination disclosure
7:30am
8-K
0v630qljl dv28
30 Aug 23
Graf Acquisition Corp. IV Announces Intent to Adjourn Special Meeting
7:30am
425
1ma k5z262fqfjv4j
24 Aug 23
Business combination disclosure
8:15am
425
2vn9j9q tglfz3xx0ia4
15 Aug 23
Business combination disclosure
4:31pm
8-K
9hy8i7 c13pqgc
15 Aug 23
Graf Acquisition Corp. Iv and Nkgen Biotech, Inc. Announce Effectiveness of Form S-4 for Proposed Business Combination
4:30pm
EFFECT
bqyqut 8b9wkyzxtxob
15 Aug 23
Notice of effectiveness
12:15am